Related Experiment Video
Updated: Sep 6, 2025
Virus Delivery of CRISPR Guides to the Murine Prostate for Gene Alteration
Published on: April 27, 2018
Suggesting Tissue-Specific MSMB Gene Promoter as a Novel Approach for Prostate Targeted Gene Therapy
Maryam Darayee1, Bita Geramizadeh2,3, Seyed Mohammad Bagher Tabei4
1Department of Molecular Medicine, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran.
Background And Aim:
Prostate cancer is the second most common cancer among men that has affected their quality of life. This study aimed to find prostate tissue-specific genes using bioinformatics methods to specifically target prostate cells in case of metastasis to other tissues.
Materials And Methods:
In this study, after finding a specific gene (MSMB) that is highly expressed in cancer, the optimal promoter region of this gene was isolated and inserted in an expression vector. Then, this vector was transfected into two prostate cancer cell lines (DU145 and LNCaP) and three non-prostate cell lines (LX-2, MRC-5, and U87) using the PEI chemical method. The expression of this vector in these cells was examined using fluorescent microscopy and flow cytometry.
Results:
We observed that the expression of MSMB promoter in DU145 cell line has a much higher activity than the CMV promoter, which is a ubiquitous promoter. The MSMB promoter didn't show any activity in cells other than that of prostate derived cell lines.
Conclusion:
MSMB gene promoter with specific expression and high efficiency in prostate tissue compared to CMV promoter can play an essential role in gene therapy of prostate cancer.
Insights
The MSMB gene promoter shows high, prostate-specific activity, making it a promising tool for targeted prostate cancer gene therapy. This discovery offers new hope for treating metastatic prostate cancer effectively.
Area of Science:
- Oncology
- Molecular Biology
- Bioinformatics
Background:
- Prostate cancer significantly impacts men's quality of life.
- Metastasis to other tissues presents a challenge in prostate cancer treatment.
Purpose of the Study:
- Identify prostate tissue-specific genes for targeted therapy.
- Evaluate the MSMB gene promoter for its specificity and efficiency in prostate cancer cells.
Main Methods:
- Bioinformatic analysis identified the MSMB gene.
- MSMB promoter was isolated and inserted into an expression vector.
- Vector transfection into prostate and non-prostate cell lines, followed by expression analysis using microscopy and flow cytometry.
Main Results:
- The MSMB promoter demonstrated significantly higher activity in DU145 prostate cancer cells compared to the CMV promoter.
- MSMB promoter activity was exclusively observed in prostate-derived cell lines, indicating tissue specificity.
- No activity was detected in non-prostate cell lines, confirming targeted expression.
Conclusions:
- The MSMB gene promoter exhibits high efficiency and prostate-specific expression.
- This promoter is a potential candidate for developing targeted gene therapy strategies for prostate cancer.
- The findings support the use of MSMB promoter in future prostate cancer treatments.
